Myo-Inositol, Berberine, and Ayurvedic Alternatives for PCOS: What The Research Shows

When you spend a few minutes reading about PCOS online, you'll probably come across the same two names again and again: Myo-Inositol and Berberine.

They're often recommended in forums, social media posts, and even conversations with healthcare professionals. Naturally, many women start wondering whether they should be taking one of them, both of them, or something else entirely.

The reason these supplements get so much attention is that PCOS affects much more than just menstrual cycles.

Many women experience a mix of symptoms that can include irregular periods, acne, unwanted facial hair, weight changes, difficulty conceiving, and challenges with blood sugar regulation. Research suggests that Myo-Inositol may support ovulation and menstrual cycle regularity in some women with PCOS. Berberine has been studied for its role in supporting blood sugar balance and metabolic health. This is one reason both continue to be widely discussed in PCOS care.

At the same time, many women are looking beyond individual supplements and exploring broader approaches to supporting their health.

This is where Ayurveda tends to look at things a little differently.

Rather than focusing on a single ingredient, traditional Ayurvedic formulations often combine multiple herbs that have historically been used to support different aspects of women's health.

Ingredients such as Ashoka, Shatavari, Lodhra, and Aparmarga have long been used in Ayurvedic practice and continue to be included in modern formulations.

The idea isn't to find an Ayurvedic version of Myo-Inositol or Berberine. It's to take a wider view of the body and recognise that symptoms such as irregular cycles, hormonal changes, and metabolic challenges are often connected.

At DurvaLife, that philosophy is paired with modern clinical research. Our Divantri PCOS Pack was evaluated in a Phase III clinical trial involving 200 participants, where researchers assessed menstrual cycle regularity, hormonal markers, ovarian health markers, and safety outcomes over 120 days. Improvements were observed across several measured outcomes during the study period.

The popularity of Myo-Inositol and Berberine reflects a broader shift in how we think about PCOS today. More women are looking beyond individual symptoms and asking bigger questions about their hormonal health, fertility, metabolism, and long-term wellbeing.

We think that's a step in the right direction.

Note: Treatment decisions should always be made in consultation with a qualified healthcare professional. Individual responses to supplements and therapies may vary.

References

International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023)

Azziz R et al. Polycystic Ovary Syndrome. Nature Reviews Disease Primers. 2016

International PCOS Network. Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS. Human Reproduction. 2018